AIF1 and schizophrenia: In agreement with the immunohistochemical data, HLA-DR, AIF1, TSPO, and CD68 mRNA levels in the midbrain did not differ between people with schizophrenia and controls (all F = 2.134, df = 1,54, p = 0.15; Fig. 2c–f).